FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1240360003: (S)-metoprolol succinate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5110523013 (S)-metoprolol succinate (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
5110524019 (S)-metoprolol succinate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
(S)-metoprolol succinate (substance) Is a Beta-1 adrenergic receptor antagonist true Inferred relationship Some
(S)-metoprolol succinate (substance) Is a Propanolamine (substance) true Inferred relationship Some
(S)-metoprolol succinate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta-1 adrenergic receptor antagonist (disposition) true Inferred relationship Some
(S)-metoprolol succinate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Metoprolol (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True (S)-metoprolol succinate (substance) Inferred relationship Some 2
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True (S)-metoprolol succinate (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start